AI Model Maps Brain Aging Pace from Longitudinal MRI
A new artificial intelligence model can measure how fast a person's brain is aging using MRI scans, providing a powerful tool for detecting cognitive decline. Unlike previous methods, this model tracks brain aging over time, identifying regions most affected and correlating changes with cognitive function. I find this development genuinely exciting because it opens a non-invasive window into brain health that blood tests simply cannot provide.
Longitudinal Model Outperforms Cross-Sectional Approaches
Researchers at USC have developed a three-dimensional convolutional neural network (3D-CNN) that offers a more precise way to measure how the brain ages over time. Created in collaboration with Paul Bogdan of the USC Viterbi School of Engineering, the model was trained and validated on more than 3,000 MRI scans of cognitively normal adults. Unlike traditional cross-sectional approaches, which estimate brain age from one scan at a single time point, this longitudinal method compares baseline and follow-up MRI scans from the same individual. As a result, it more accurately pinpoints neuroanatomic changes tied to accelerated or decelerated aging. The 3D-CNN also generates interpretable "saliency maps," which indicate the specific brain regions that are most important for determining the pace of aging. I especially appreciate that these saliency maps make the model's decisions interpretable rather than a black box.
Strong Correlation Between Brain Aging Speed and Cognitive Decline
When applied to a group of 104 cognitively healthy adults and 140 Alzheimer's disease patients, the new model's calculations of brain aging speed closely correlated with changes in cognitive function tests given at both time points. "The alignment of these measures with cognitive test results indicates that the framework may serve as an early biomarker of neurocognitive decline," said Paul Bogdan. "Moreover, it demonstrates its applicability in both cognitively normal individuals and those with cognitive impairment." Andrei Irimia, senior author of the study, added: "Rates of brain aging are correlated significantly with changes in cognitive function. So, if you have a high rate of brain aging, you're more likely to have a high rate of degradation in cognitive function, including memory, executive speed, executive function, and processing speed. It's not only an anatomic measure; the changes we see in the anatomy are associated with changes we see in the cognition of these individuals." The longitudinal model achieves a mean absolute error (MAE) of 0.16 years (7% mean error) compared to the cross-sectional model's MAE of 1.85 years (83% error). This significantly outperforms previous methods.
Saliency Maps Reveal Key Brain Regions
The model generates interpretable saliency maps showing brain regions most important for aging pace. Researchers found that rates of brain aging in certain regions differed between the sexes, which might shed light on why men and women face different risks for neurodegenerative disorders, including Alzheimer's. This sex-specific patterning could explain differential susceptibility to cognitive decline between genders. I notice this sex difference aligns with what we already know about gender disparities in Alzheimer's disease prevalence, making it a potentially important clinical clue.
Potential for Alzheimer's Risk Estimation
The model has the potential to estimate individual risk for Alzheimer's disease. Irimia noted: "One thing that my lab is very interested in is estimating risk for Alzheimer's; we'd like to one day be able to say, 'Right now, it looks like this person has a 30% risk for Alzheimer's.' We're not there yet, but we're working on it." Irimia believes this kind of measure will be very helpful to produce variables that are prognostic and can help forecast Alzheimer's risk, especially as potential prevention drugs develop. I confess I'm skeptical we'll ever get precise percentage risks for individual patients, but even rough directional estimates could transform how we approach early intervention.
Biological Age Versus Chronological Age
Biological age is distinct from an individual's chronological age. Two people who are the same age based on their birthdate can have very different biological ages. While common measures of biological age use blood samples to measure epigenetic aging and DNA methylation, Irimia explained that measuring biological age from blood samples is a poor strategy for measuring the brain's age because the blood-brain barrier prevents blood cells from crossing into the brain. MRI-based approaches offer a non-invasive alternative that directly captures brain aging without the limitations of blood-based biomarkers. This distinction matters because many people assume a blood test can tell them their "brain age," when fundamentally that science isn't there yet.
Study Support and Scope
The study received funding from the National Institutes of Health (NIH), Department of Defense, National Science Foundation, U.S. Army Research Office, DARPA, Intel, Northrop Grumman, and other organizations. The research complements existing strategies for Alzheimer's risk assessment that estimate individuals' rates of adverse cognitive change with age.
Summary
This AI model represents a significant advancement in quantifying the pace of brain aging in relation to neurocognitive changes. By leveraging longitudinal MRI data and providing interpretable regional insights, it offers a non-invasive tool for early detection of cognitive decline and potential Alzheimer's risk assessment. The alignment of these measures with cognitive test results indicates that the framework may serve as an early biomarker of neurocognitive decline, demonstrating applicability in both cognitively normal individuals and those with cognitive impairment.
Source: https://neurosciencenews.com/ai-brain-aging-cognition-28435/